International Pediatric Adrenocortical Tumor Registry

Conditions

• Adrenocortical Tumor

Eligibility Criteria

Sex

ALL

Age

N/A - 21 Years

Healthy Volunteers

Not accepted

Study Details

This study aims to collect demographic and medical information including detailed family history of cancer of children and adolescents with adrenocortical tumors in order to learn more about the clinical and epidemiological aspects, treatment modalities, and outcome of patients with this rare disease, worldwide. In addition, investigators at St. Jude Children's Research Hospital (SJCRH) plan to perform molecular studies of tumor cells aimed to clarify the role of the TP53 gene and other genetic pathways in these tumors. They aim to obtain relevant biological material from participants with adrenocortical tumor (ACT), their biological parents, and relatives for determination of the TP53 germline status, molecular studies of the TP53 gene, and other molecular pathways.

Key Dates

Start date

Oct 1, 2001

Status verified

May 2026

Primary completion

Dec 31, 2040

Completion

Dec 31, 2040

Study Design

Enrollment

9,999 participants (estimated)

Arms

• Arm: Participants
  Any participant who meets eligibility criteria and consents to participate in the trial.

Primary Outcome Measure

Collect demographic/medical information, detailed family history of cancer of children/adolescents with adrenocortical tumors, learn more about the clinical and epidemiological aspects, treatment modalities, and outcome of patients [ Time Frame: Annually from diagnosis until no longer being followed, defined as up to 5 years from the date of last follow-up ]

Central Contacts

• Raul C Ribeiro, MD
  866-278-5833
  [email protected]

Locations (5)

Find similar trials in Stanford, CA